menu
    • menu

    Company profile for Eyenovia

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthrough treatments for front and back-of-the-eye diseases, which are made possible by the company’s transformative, high precision ophthalmic delivery platform. Eyenovia’s pipeline is currently focused on the development of four programs including myopia (nearsightedness) progression, glaucoma and other eye diseases

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EyenoviaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    295 Madison Ave, Suite 2400, New York, New York 10017, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eyenovia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hyperion DeFi's Corporate Update and Q2 2025 Financial Results
    Hyperion DeFi's Corporate Update and Q2 2025 Financial Results

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132948/0/en/Hyperion-DeFi-Provides-Corporate-Update-and-Reports-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    Hyperion DeFi to Host Event on Strategic Evolution from Eyenovia
    Hyperion DeFi to Host Event on Strategic Evolution from Eyenovia

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3117134/0/en/Hyperion-DeFi-to-Host-Corporate-Update-Event-to-Discuss-Strategic-Evolution-from-Eyenovia-and-the-Future-of-On-Chain-Finance-on-July-29-2025.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    Eyenovia rebrands to Hyperion DeFi
    Eyenovia rebrands to Hyperion DeFi

    02 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/02/3109117/0/en/Eyenovia-Announces-Rebranding-and-Corporate-Name-Change-to-Hyperion-DeFi-Inc.html

    GLOBENEWSWIRE
    02 Jul 2025
    Share Share
    Eyenovia Adds $10 Million in HYPE for Strategic Engagement
    Eyenovia Adds $10 Million in HYPE for Strategic Engagement

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107426/0/en/Eyenovia-Adds-10-Million-in-HYPE-to-its-Treasury-Holdings-in-Preparation-for-Strategic-Onchain-Engagement.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share
    Eyenovia Announces Co-Branded Validator with Kinetiq
    Eyenovia Announces Co-Branded Validator with Kinetiq

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105095/0/en/Eyenovia-Announces-Co-Branded-Validator-with-Kinetiq.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Eyenovia Closes $50M Round, Hits 1M HYPE Tokens Collected
    Eyenovia Closes $50M Round, Hits 1M HYPE Tokens Collected

    23 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/23/3103404/0/en/Eyenovia-Announces-Closing-of-50-Million-Private-Placement-Successful-Accumulation-of-More-Than-One-Million-HYPE-Tokens-and-Update-on-its-Optejet-Development-Program.html

    GLOBENEWSWIRE
    23 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search